A resource to keep Wirral University Teaching Hospital (WUTH) and Wirral Community Health and Care Trust (WCHCT) staff and students on placement up to date with the latest developments, news and events relating to library, research and evidence based practice within the organisation. Brought to you as a collaborative venture between the Library & Knowledge Service and the WUTH Research & Development department.
Tracking
Thursday, 22 October 2020
WUTH publication: Is "no test is better than a bad test"? Impact of diagnostic uncertainty in mass testing on the spread of COVID-19
Thursday, 15 October 2020
WUTH publication: Acute ischaemic stroke management: Concepts and Controversies. A narrative review
Friday, 9 October 2020
Visit the library
Please do come along and visit the McArdle Library.
We have a number of measures in place to limit COVID. Please:
· wear a face mask
· sign the visitor's book
· sanitise hands frequently & use wipes provided to clean PCs/desk
· observe social distancing
Let's work together & keep everyone safe
Friday, 2 October 2020
WUTH publication: Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group
WUTH publication: A prospective, multi-centre external validation study of the Liverpool Peritonsillar abscess Score (LPS) with a no-examination Covid-19 modification
Tuesday, 29 September 2020
WUTH publication: Refocusing cancer multidisciplinary team meetings in the United Kingdom: comparing urology with other specialties
Citation: Annals of the Royal College of Surgeons of England. 2021, 103(1), 10-17. Epub 2020 Sep 28
Author: Warner R, Hoinville L, Pottle E, Taylor C, Green J
Abstract: INTRODUCTION: Multidisciplinary team (MDT) meetings have been the gold standard of cancer care in the UK since the 1990s. We aimed to identify the views of urology cancer MDT members in the UK on improving the functioning of meetings and compare them with those of other specialties to manage the increasing demand on healthcare resources and enhance the care of complex cancer cases.
METHODS: We analysed data from 2 national surveys distributed by Cancer Research UK focusing on the views of 2294 and 1258 MDT members about cancer MDT meetings.
FINDINGS: Most breast, colorectal, lung and urology cancer MDT members felt meetings could be improved in the following areas: time for meeting preparation in job plans, streamlining of patients, auditing meeting decisions and prioritising complex cases. Most urology respondents (87%) agreed some patients could be managed outside a full MDT discussion, but this was lower for other specialties (lung 78%, breast 75%, colorectal 64%).
CONCLUSIONS: To facilitate decisions on which patients require discussion in an MDT meeting, factors adding to case complexity across all tumour types were identified, including rare tumour type, cognitive impairment and previous treatment failure. This study confirms that urology MDT members are supportive of changing from reviewing all new cancer diagnoses to discussing complex cases but managing others with a more protocolised pathway. The mechanisms for how to do this and how to ensure the safety of patients require further clarification.
WUTH publication: The Critical Roles and Mechanisms of Immune Cell Death in Sepsis
Friday, 25 September 2020
CCC publication: Beam characterisation studies of the 62 MeV proton therapy beamline at the Clatterbridge Cancer Centre
CCC publication: Proton ocular centers with dedicated fixed low-energy beams: Key concepts for new centers
Abstract: Purpose : Proton beam treatment for uveal melanoma (UM) has been well established internationally with dedicated ocular beamlines. With the emergence of universal, high-energy, non-fixed beamlines, we share key practices to minimize side effects. Methods : The University of California, San Francisco (UCSF), USA, and the Clatterbridge Cancer Centre (CCC), UK, both have longstanding facilities with dedicated, fixed, low-energy, ocular lines, which produce 67.5 and 60.0 MeV proton beams, respectively (range up to 3 cm). In total 5927 ocular patients, 93% with UM, have been treated. Standard UM dose is 56 Gray Equivalent (GyE) at UCSF and 57.2 GyE at CCC, delivered in 4 fractions. Planning and delivery procedures were analyzed as a bi-institutional effort to communicate key concepts to developing centers. Results : Low-energy dedicated eye beamlines provide critical beam characteristics for normal eye tissue sparing. Both centers offer a very sharp dose fall off (distal ~1 mm and lateral ~1.1-1.6 mm), high dose homogeneity, excellent range precision and short treatment time (~0.5-2 minutes). Analyses confirm that planned doses to critical ocular structures are independent predictors of vision, neovascular glaucoma, and other clinical outcomes (e.g. 28 GyE to macula [P<.0001], optic nerve [P<0.0004], lens [P<.0001], and ciliary body [P<.0001]). A rational tumor/critical structure dose evaluation is used to optimize treatment parameters, i.e. lateral margin, distal range, gaze angle, and aperture shape. New high-energy non-dedicated beam designs, which degrade energy to deliver ocular treatment, may require significant beam adjustment and treatment planning procedures to achieve adequate characteristics. A common dosing regimen for UM is 60 GyE in 4 fractions globally. Unrandomized early retrospective data showed lower local tumor control with 48 GyE (P=0.02). Critical structures including the retina, lacrimal gland, cornea, tear ducts, lids, bony orbit, and limbal stem cells are systematically evaluated to minimize side effects. Eyelid toxicity is minimized by retraction techniques or treatment through closed lids. Conclusions : Experienced proton centers at UCSF and CCC with dedicated, low-energy, fixed eyelines, provide important practical clinical concepts for consideration by new centers to optimize high-energy universal beamline designs, particularly to reduce normal tissue toxicity.